Kazuhiro Hirohashi

TL;DR: Findings indicate that CK19 expression is a predictor of early postoperative recurrence due to increased invasiveness in patients with CK19‐positive hepatocellular carcinoma.

TL;DR: This study conducted a randomized, controlled trial to evaluate whether postoperative therapy with interferon- would decrease the incidence of recurrence after resection of HCV-related hepatocellular carcinoma.

TL;DR: Elevated PVP in the early phase is strongly associated with poor patient survival attributable, at least in part, to small-for-size graft, and further elucidation of the pathogenesis behind this phenomenon and efforts to modify PVP will be key to improving results.

TL;DR: Patients with hepatolithiasis should be kept in mind if there are high levels of CEA, if the location of the stones is classified as type I-L, or if portal veins cannot be seen on portograms, and liver resection should be considered because there may be undiagnosed cholangiocarcinoma.

TL;DR: HCV infection is a likely etiology of ICC in Japan and anti‐HCV antibodies were found to be independent risk factors for ICC development, as liver status worsened, the adjusted OR for ICC tended to increase.